The Paradox of Invisible Infrastructure
Every few years, a Congressional budget cycle surfaces the same idea: eliminate or curtail the Qualified Small Business Stock exclusion under Section 1202 of the tax code. The logic is straightforward on its face. Treasury estimates that repealing QSBS would raise roughly $44.6 billion over the 2025-2034 window. Critics point out that the wealthiest tax filers account for approximately 75% of the capital gains excluded under the provision. The optics are clean --- close a tax break that disproportionately benefits the rich, use the revenue for broadly popular programs.
The logic is also wrong. Not because the distributional data is inaccurate, but because it fundamentally misunderstands what QSBS does and why it exists. I have spent my career in the infrastructure layer of venture capital, watching how tax incentives and regulatory exemptions shape capital allocation decisions in real time. QSBS and Regulation D are not loopholes. They are load-bearing walls in the architecture of American innovation. Removing them would not redistribute wealth. It would reduce the total amount of wealth created.
What QSBS Actually Incentivizes
Section 1202 was enacted in 1993 with a specific policy objective: encourage patient capital investment in small businesses by reducing the tax penalty for success. The mechanism is straightforward. If you invest in a qualified small business --- a domestic C-corporation with gross assets under a certain threshold --- and hold that stock for at least five years, you can exclude up to 100% of your capital gains from federal tax. The 2025 expansion raised the asset cap from $50 million to $75 million and the per-taxpayer benefit cap from $10 million to $15 million.
The five-year holding requirement is the critical design feature. QSBS does not reward short-term speculation. It rewards exactly the behavior that the startup ecosystem needs most: investors who commit capital to high-risk ventures and then wait. In a world where the median company takes thirteen or fourteen years to reach an IPO, patient capital is not a luxury. It is the essential ingredient.
The criticism that wealthy investors capture most of the benefit is accurate but misleading. Wealthy investors write most of the checks into early-stage companies. That is a distributional problem worth addressing through other mechanisms --- broadening investor access, expanding who can participate in private markets --- but it is not an argument for eliminating the incentive that makes those investments rational in the first place. The expected return on a seed-stage venture investment, adjusted for the roughly 70% failure rate of startups, is marginal even with QSBS. Remove the exclusion, and the risk-adjusted math tilts decisively against early-stage investing for many allocators.
There is also a structural limitation that tempers the scope of the benefit: fewer than 10% of small businesses in America are organized as C-corporations. QSBS does not apply to LLCs, S-corps, partnerships, or sole proprietorships. The provision is narrowly targeted at the subset of businesses most likely to raise outside equity capital, grow rapidly, and generate the kind of innovation-driven returns that produce broad economic benefits. It is not a blanket subsidy for small business.
Regulation D: The Engine Nobody Talks About
If QSBS is the incentive that makes early-stage investing rational, Regulation D is the mechanism that makes it possible. Reg D provides the exemption from SEC registration that allows private companies to raise capital from accredited investors without the enormous cost and disclosure burden of a public offering. In 2024, Reg D offerings raised approximately $2.15 trillion. In 2025, that figure climbed to $2.4 trillion.
To appreciate the scale: over the period from 2009 to 2020, companies and funds raised a cumulative $15 trillion through Reg D offerings. By comparison, Regulation A --- the "mini-IPO" exemption --- raised $896 million in 2024. Regulation Crowdfunding raised $179 million. Reg D is not one capital formation pathway among equals. It is the capital formation pathway for private markets, dwarfing every alternative by orders of magnitude.
The periodic calls to restrict Reg D typically focus on investor protection concerns --- the risk that unsophisticated investors will lose money in opaque private offerings. These concerns are not frivolous, but they must be weighed against what Reg D actually enables. Every venture-backed company in America raises its early capital through Reg D. Every venture fund is structured as a Reg D offering. The entire ecosystem of innovation finance --- from pre-seed rounds to growth equity --- runs on this regulatory infrastructure.
Increasing the compliance burden on Reg D offerings would not protect investors. It would raise the cost of capital formation, which would disproportionately harm the smallest and earliest-stage companies that can least afford additional legal and administrative expenses. The companies with the resources to absorb higher compliance costs are precisely the ones that need Reg D least.
Honest Accounting
I want to engage honestly with the strongest version of the opposing argument. The $44.6 billion revenue estimate for repealing QSBS is real money. The concentration of benefits among wealthy filers is real. The opacity of private markets creates real information asymmetries that disadvantage less sophisticated participants. These are legitimate concerns, and dismissing them weakens the case for preservation.
But policy analysis requires comparing alternatives, not evaluating provisions in isolation. The relevant question is not whether QSBS costs revenue. It does. The relevant question is whether the economic activity generated by QSBS-incentivized investment produces sufficient tax revenue, job creation, and innovation to justify the foregone revenue. The venture capital ecosystem --- built on the twin foundations of QSBS and Reg D --- has funded companies that collectively employ millions of Americans, generate hundreds of billions in annual revenue, and pay substantial corporate and payroll taxes. The counterfactual world without these incentives is not one where the same companies exist and the government simply collects more tax. It is one where many of those companies are never funded in the first place.
What Responsible Reform Looks Like
None of this means QSBS and Reg D are perfect as designed. There are reasonable reforms that would improve both provisions without undermining their core function. Expanding the definition of accredited investor would broaden participation in Reg D offerings. Adjusting QSBS thresholds for inflation on a regular basis would prevent arbitrary erosion of the benefit. Improving disclosure requirements for Reg D offerings would enhance transparency without imposing prohibitive costs.
What would be irresponsible is dismantling these provisions to score short-term budgetary wins. QSBS and Reg D are the product of decades of iterative policy development. They are embedded in the capital allocation decisions of every venture fund, every startup, and every angel investor in the country. Their elimination would not simply change the tax code. It would destabilize the incentive structure that drives risk capital into the highest-impact, highest-uncertainty ventures --- the exact ventures that produce transformational innovation.
The infrastructure of innovation is largely invisible to policymakers because it works. Reg D offerings do not generate headlines. QSBS exclusions do not produce ribbon-cutting ceremonies. But they undergird the system that turns ideas into companies and companies into industries. We should fix what needs fixing and preserve what is working. These provisions are working.